These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 30959067

  • 1. Comparison of Clinical Features and Visual Outcome between Sympathetic Ophthalmia and Vogt-Koyanagi-Harada Disease in Chinese Patients.
    Yang P, Liu S, Zhong Z, Du L, Ye Z, Zhou W, Kijlstra A.
    Ophthalmology; 2019 Sep; 126(9):1297-1305. PubMed ID: 30959067
    [Abstract] [Full Text] [Related]

  • 2. Clinical characteristics of Vogt-Koyanagi-Harada syndrome in Chinese patients.
    Yang P, Ren Y, Li B, Fang W, Meng Q, Kijlstra A.
    Ophthalmology; 2007 Mar; 114(3):606-14. PubMed ID: 17123618
    [Abstract] [Full Text] [Related]

  • 3. Retinal vessel oxygen saturation is affected in uveitis associated with Vogt-Koyanagi-Harada disease.
    Abu El-Asrar AM, AlBloushi AF, Gikandi PW, Hardarson SH, Stefánsson E.
    Br J Ophthalmol; 2019 Dec; 103(12):1695-1699. PubMed ID: 30798260
    [Abstract] [Full Text] [Related]

  • 4. Acute phase clinical manifestations of patients with Vogt-Koyanagi-Harada disease in Southern China.
    Zhang C, Wang Y, Chen Y, Zhou H, Hong Q, Yu X, Ng TK, Cen LP.
    BMC Ophthalmol; 2023 May 05; 23(1):199. PubMed ID: 37147563
    [Abstract] [Full Text] [Related]

  • 5. The outcomes of mycophenolate mofetil therapy combined with systemic corticosteroids in acute uveitis associated with Vogt-Koyanagi-Harada disease.
    Abu El-Asrar AM, Hemachandran S, Al-Mezaine HS, Kangave D, Al-Muammar AM.
    Acta Ophthalmol; 2012 Dec 05; 90(8):e603-8. PubMed ID: 22971163
    [Abstract] [Full Text] [Related]

  • 6. Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of 'sunset glow fundus' in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease.
    Abu El-Asrar AM, Dosari M, Hemachandran S, Gikandi PW, Al-Muammar A.
    Acta Ophthalmol; 2017 Feb 05; 95(1):85-90. PubMed ID: 27535102
    [Abstract] [Full Text] [Related]

  • 7. Incidence and clinical features of recurrent Vogt-Koyanagi-Harada disease in Japanese individuals.
    Iwahashi C, Okuno K, Hashida N, Nakai K, Ohguro N, Nishida K.
    Jpn J Ophthalmol; 2015 May 05; 59(3):157-63. PubMed ID: 25808016
    [Abstract] [Full Text] [Related]

  • 8. [Clinical manifestations and diagnosis of Vogt-Koyanagi-Harada syndrome].
    Yang P, Wang H, Zhou H, Huang X, Zhong H, Chen L, Zhong H, Fu T.
    Zhonghua Yan Ke Za Zhi; 2002 Dec 05; 38(12):736-9. PubMed ID: 12654224
    [Abstract] [Full Text] [Related]

  • 9. Vogt-Koyanagi-Harada disease in Hispanic patients.
    Sukavatcharin S, Tsai JH, Rao NA.
    Int Ophthalmol; 2007 Dec 05; 27(2-3):143-8. PubMed ID: 17380271
    [Abstract] [Full Text] [Related]

  • 10. Long-term efficacy of dexamethasone intravitreal implant in the treatment of Vogt-Koyanagi-Harada disease relapsing posterior uveitis.
    Elhamaky TR.
    Indian J Ophthalmol; 2022 Jul 05; 70(7):2465-2470. PubMed ID: 35791135
    [Abstract] [Full Text] [Related]

  • 11. Outcome and Prognostic Factors of Phacoemulsification Cataract Surgery in Vogt-Koyanagi-Harada Uveitis.
    Ji Y, Hu K, Li C, Li P, Kijlstra A, Eghrari AO, Lei B, Du L, Wan W, Yang P.
    Am J Ophthalmol; 2018 Dec 05; 196():121-128. PubMed ID: 30194930
    [Abstract] [Full Text] [Related]

  • 12. Choroidal circulation impairment during the anterior recurrence of Vogt-Koyanagi-Harada disease confirmed with indocyanine green angiography and laser speckle flowgraphy.
    Takemoto Y, Namba K, Mizuuchi K, Iwata D, Uno T, Ohno S, Hirooka K, Hashimoto Y, Saito W, Sugiyama K, Ishida S.
    Acta Ophthalmol; 2016 Nov 05; 94(7):e629-e636. PubMed ID: 27079805
    [Abstract] [Full Text] [Related]

  • 13. Prognostic factors in Vogt-Koyanagi-Harada disease.
    Al-Kharashi AS, Aldibhi H, Al-Fraykh H, Kangave D, Abu El-Asrar AM.
    Int Ophthalmol; 2007 Nov 05; 27(2-3):201-10. PubMed ID: 17435968
    [Abstract] [Full Text] [Related]

  • 14. The outcomes of indocyanine green angiography monitored immunotherapy in Vogt-Koyanagi-Harada disease.
    Chee SP, Jap A.
    Br J Ophthalmol; 2013 Feb 05; 97(2):130-3. PubMed ID: 23212203
    [Abstract] [Full Text] [Related]

  • 15. Indocyanine green angiographic findings in initial-onset acute Vogt-Koyanagi-Harada disease.
    Abouammoh MA, Gupta V, Hemachandran S, Herbort CP, Abu El-Asrar AM.
    Acta Ophthalmol; 2016 Sep 05; 94(6):573-8. PubMed ID: 26823203
    [Abstract] [Full Text] [Related]

  • 16. Clinical features and visual outcomes of 111 patients with new-onset acute Vogt-Koyanagi-Harada disease treated with pulse intravenous corticosteroids.
    Nakayama M, Keino H, Watanabe T, Okada AA.
    Br J Ophthalmol; 2019 Feb 05; 103(2):274-278. PubMed ID: 29666121
    [Abstract] [Full Text] [Related]

  • 17. Outcomes of initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease occurred during pregnancy.
    Alromaih AZ, Almater AI, Albloushi AF, Alkheraiji NF, Abu El-Asrar AM.
    Int Ophthalmol; 2023 Jan 05; 43(1):185-195. PubMed ID: 35945413
    [Abstract] [Full Text] [Related]

  • 18. Novel treatment regimen of Vogt-Koyanagi-Harada disease with a reduced dose of corticosteroids combined with immunosuppressive agents.
    Yang P, Ye Z, Du L, Zhou Q, Qi J, Liang L, Wu L, Wang C, Kijlstra A.
    Curr Eye Res; 2018 Feb 05; 43(2):254-261. PubMed ID: 29111815
    [Abstract] [Full Text] [Related]

  • 19. Decrease of choriocapillary vascular density measured by optical coherence tomography angiography in Vogt-Koyanagi-Harada disease.
    Liang A, Jia S, Gao F, Han X, Pei M, Qu Y, Xiao J, Zhao C, Zhang M.
    Graefes Arch Clin Exp Ophthalmol; 2021 Nov 05; 259(11):3395-3404. PubMed ID: 34216256
    [Abstract] [Full Text] [Related]

  • 20. Incidence, Risk Factors and Surgical Outcomes of Cataract among Patients with Vogt-Koyanagi-Harada Disease.
    AlBloushi AF, Alfawaz AM, AlZaid A, Alsalamah AK, Gikandi PW, Abu El-Asrar AM.
    Ocul Immunol Inflamm; 2021 Jan 02; 29(1):128-136. PubMed ID: 31638886
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.